Aditxt (ADTX) Competitors $0.97 -0.04 (-3.96%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$0.98 +0.01 (+1.03%) As of 09/19/2025 07:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADTX vs. FNCH, ALVR, TLPH, LSTA, SYBX, PRPH, THAR, IBIO, LSB, and BLRXShould you be buying Aditxt stock or one of its competitors? The main competitors of Aditxt include Finch Therapeutics Group (FNCH), AlloVir (ALVR), Talphera (TLPH), Lisata Therapeutics (LSTA), Synlogic (SYBX), ProPhase Labs (PRPH), Tharimmune (THAR), iBio (IBIO), LakeShore Biopharma (LSB), and BioLineRx (BLRX). These companies are all part of the "pharmaceutical products" industry. Aditxt vs. Its Competitors Finch Therapeutics Group AlloVir Talphera Lisata Therapeutics Synlogic ProPhase Labs Tharimmune iBio LakeShore Biopharma BioLineRx Finch Therapeutics Group (NASDAQ:FNCH) and Aditxt (NASDAQ:ADTX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability, media sentiment and risk. Do insiders & institutionals believe in FNCH or ADTX? 21.8% of Finch Therapeutics Group shares are owned by institutional investors. Comparatively, 15.5% of Aditxt shares are owned by institutional investors. 44.9% of Finch Therapeutics Group shares are owned by insiders. Comparatively, 0.0% of Aditxt shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has higher earnings & valuation, FNCH or ADTX? Aditxt has higher revenue and earnings than Finch Therapeutics Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFinch Therapeutics GroupN/AN/A-$74.75M-$8.82-1.38Aditxt$130K37.16-$34.45MN/AN/A Is FNCH or ADTX more profitable? Finch Therapeutics Group has a net margin of 0.00% compared to Aditxt's net margin of -206,431.38%. Finch Therapeutics Group's return on equity of -69.14% beat Aditxt's return on equity.Company Net Margins Return on Equity Return on Assets Finch Therapeutics GroupN/A -69.14% -26.92% Aditxt -206,431.38%-316.98%-80.88% Does the media refer more to FNCH or ADTX? In the previous week, Aditxt had 2 more articles in the media than Finch Therapeutics Group. MarketBeat recorded 2 mentions for Aditxt and 0 mentions for Finch Therapeutics Group. Finch Therapeutics Group's average media sentiment score of 0.00 equaled Aditxt'saverage media sentiment score. Company Overall Sentiment Finch Therapeutics Group Neutral Aditxt Neutral Which has more risk & volatility, FNCH or ADTX? Finch Therapeutics Group has a beta of 1.2, suggesting that its stock price is 20% more volatile than the S&P 500. Comparatively, Aditxt has a beta of 1.51, suggesting that its stock price is 51% more volatile than the S&P 500. SummaryFinch Therapeutics Group beats Aditxt on 5 of the 9 factors compared between the two stocks. Get Aditxt News Delivered to You Automatically Sign up to receive the latest news and ratings for ADTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ADTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADTX vs. The Competition Export to ExcelMetricAditxtMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.83M$2.57B$5.79B$10.47BDividend YieldN/A55.05%5.61%4.61%P/E RatioN/A4.9660.4922.62Price / Sales37.16695.15538.75129.08Price / CashN/A172.2337.6661.43Price / Book-0.645.3515.756.39Net Income-$34.45M$32.95M$3.30B$271.80M7 Day Performance-3.96%0.90%5.36%3.49%1 Month Performance-6.73%5.76%8.10%9.90%1 Year Performance-99.97%-3.43%81.36%28.62% Aditxt Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADTXAditxtN/A$0.97-4.0%N/A-100.0%$4.83M$130K0.0060FNCHFinch Therapeutics GroupN/A$12.40-2.1%N/A+4.6%$19.91MN/A-1.41190Gap DownALVRAlloVirN/A$3.89-9.1%N/A-75.8%$19.62MN/A-0.19110High Trading VolumeTLPHTalphera1.8913 of 5 stars$0.98+4.3%$5.00+410.2%-9.7%$19.29M$650K-2.4519Gap DownLSTALisata Therapeutics3.178 of 5 stars$2.12-3.2%$23.50+1,008.5%-23.6%$19.18M$1M-0.9530Short Interest ↓Gap DownSYBXSynlogic0.7512 of 5 stars$1.65+3.5%N/A+21.9%$18.60M$10K-20.5780News CoverageShort Interest ↓PRPHProPhase Labs0.5073 of 5 stars$0.43-0.8%N/A-84.6%$18.01M$6.77M-0.34130THARTharimmune1.8809 of 5 stars$2.94-6.4%$17.00+478.2%+20.4%$17.87MN/A-0.482Gap DownIBIOiBio1.621 of 5 stars$0.89-4.2%$5.00+458.9%-54.3%$17.58M$400K-0.51100LSBLakeShore Biopharma0.7001 of 5 stars$0.81-3.1%N/A-91.6%$17.25M$85.67M0.00773BLRXBioLineRx2.616 of 5 stars$3.75-7.2%$26.00+593.3%-85.7%$17.22M$28.94M-0.4340Positive News Related Companies and Tools Related Companies Finch Therapeutics Group Alternatives AlloVir Alternatives Talphera Alternatives Lisata Therapeutics Alternatives Synlogic Alternatives ProPhase Labs Alternatives Tharimmune Alternatives iBio Alternatives LakeShore Biopharma Alternatives BioLineRx Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADTX) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aditxt, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aditxt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
